(1-3). Proportions of patients with ≥ 2 points and 0-1 points in the SAMe-TT 2 R 2 score who had the time in therapeutic range (TTR) ≤ 70% were similar (61 [67%] vs. 63 [56%], p = 0.11). A modified score, involving medical history (myocardial infarction [MI] and chronic obstructive pulmonary disease [COPD], 1 point), statin treatment (1 point) and tobacco use (2 points) had a higher area under the curve (AUC) in patients on acenocoumarol compared to p = 0.042 (Cardiol J 2017; 24, 5: 477-483)